Status:
UNKNOWN
An Electronic Pillbox for People With HIV
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
Anti-HIV drug regimens can be very complicated. This study will evaluate a new electronic pillbox designed to help people take their anti-HIV drugs correctly.
Detailed Description
Recent advances in antiretroviral therapy have allowed for almost complete inhibition of viral replication in HIV-infected individuals. Unfortunately, the ability of the virus to rapidly mutate and be...
Eligibility Criteria
Inclusion
- HIV-infected for at least six months prior to study entry
- Currently taking at least one and not more than four antiretroviral medications (not including medications for prophylaxis or unrelated disorders)
- Understand the benefits of antiviral medications in reducing viral load, boosting immune response, and preventing opportunistic infections
- Desire to take all antiretroviral medication as scheduled
- Working telephone
- Ambulatory
- Good mental health
Exclusion
- Require assistance dispensing or taking medications
- Require full or part time assistance with the activities of daily living
- Does not intend to take all anti-HIV medication over the course of the study
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00071500
Start Date
October 1 2003
End Date
June 1 2009
Last Update
September 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LIFETECHniques, Inc.
Santa Barbara, California, United States, 93101